p34cdc2 in invasive breast cancer:: relationship to DNA content, Ki67 index and c-erbB-2 expression

被引:0
|
作者
Wiesener, B
Hauser-Kronberger, CE
Zipperer, E
Dietze, O
Menzel, C
Hacker, GW
机构
[1] Gen Hosp, St Johanns Spital, Inst Pathol Anat, A-5020 Salzburg, Austria
[2] Gen Hosp, St Johanns Spital, Dept Gynecol & Obstet, A-5020 Salzburg, Austria
关键词
c-erbB-2; DNA ploidy; invasive mammary carcinoma; Ki67; p34(cdc2);
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: One-hundred and eighty-eight cases of human mammary carcinoma were examined immunohistochemically for their expression of Ki67, p34(cdc2) and c-erbB-2. DNA image cytometry was performed to evaluate DNA ploidy, Auer type, S-phase fraction (SPF), 5c exceeding rate (5cER) and 2c deviation index (2cDI). Methods and results: One-hundred and sixty-eight cases were invasive ductal carcinomas, 20 were of invasive lobular type. Routinely assessed oestrogen and progesterone receptor scores were available, The results were analysed statistically in comparison to tumour type, histopathological grade, lymph node status, menopausal status, patient age and overall survival. Ki67 (P<0.002) and c-erbB-2 (P<0.0001) correlated well with overall survival (P<0.0008) and grade (P<0.038) but not: with lymph node status and tumour type. p34cdc2 showed a trend towards a positive correlation with Ki67 (P<0.058) and a significant negative correlation with receptor status (P<0.008) but with none of the other parameters examined. Conclusions: No association between the DNA measured parameters (Auer type, SPF, 5cER and 2cDI) and survival was found. Our results suggest that c-erbB-2 and Ki67 are parameters which might, in combination with receptor status, help to define subgroups with different outcomes.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 50 条
  • [41] PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 EXPRESSION IN INVASIVE DUCTAL CARCINOMA OF THE BREAST
    HORIGUCHI, J
    LINO, Y
    TAKEI, H
    MORISHITA, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1995, 25 (04) : 119 - 123
  • [42] Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features
    Shpitz, B
    Bomstein, Y
    Sternberg, A
    Klein, E
    Tiomkin, V
    Kaufman, A
    Groisman, G
    Bernheim, J
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (02) : 86 - 92
  • [43] DNA ploidy, p53 and c-erbB-2 overexpression and Ki-67 staining pattern in Barrett's esophagus (BE).
    Petraki, K
    Mantzaris, G
    Papadopoulos, S
    Petraki, C
    Sotiropoulou, M
    Michopoulos, S
    GASTROENTEROLOGY, 2001, 120 (05) : A417 - A417
  • [44] C-erbB-2、p53、CathD及Ki67基因在乳腺癌中表达及意义
    施为建
    米贤军
    杨接辉
    梅俪凡
    周巧云
    医药论坛杂志, 2005, (11) : 8 - 10
  • [45] ki67、c-erbB-2在结肠癌及腺瘤中的表达及意义
    梁喜林
    刘志远
    赵红
    郑晓芙
    中国现代医生, 2007, (03) : 13+47 - 13
  • [46] Tissue and serum expression of c-erbB-2 protein in breast cancer.
    Covello, M
    Labriola, A
    Venneri, MT
    Italia, A
    Zito, A
    Marzullo, F
    Quaranta, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 618 - 618
  • [47] Molecular markers (c-erbB-2, p53) in breast cancer
    Agrawal, Anil Kumar
    Jelen, Michal
    Rudnicki, Jerzy
    Grzebieniak, Zygmunt
    Zukrowski, Piotr
    Nienartowicz, Ewa
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (04) : 449 - 455
  • [48] IMMUNOHISTOCHEMICAL STUDY ON THE EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN BREAST-CANCER
    HORIGUCHI, J
    IINO, Y
    TAKEI, H
    YOKOE, T
    ISHIDA, T
    MORISHITA, Y
    ONCOLOGY, 1994, 51 (01) : 47 - 51
  • [49] C-ERBB-2 PROTEIN EXPRESSION IN NODE NEGATIVE BREAST-CANCER
    RICHNER, J
    GERBER, HA
    LOCHER, GW
    GOLDHIRSCH, A
    GELBER, RD
    GULLICK, WJ
    BERGER, MS
    GRONER, B
    HYNES, NE
    ANNALS OF ONCOLOGY, 1990, 1 (04) : 263 - 268
  • [50] C-ERBB-2 EXPRESSION IN BREAST-CANCER DETECTED BY IMMUNOBLOTTING AND IMMUNOHISTOCHEMISTRY
    KERNS, BJM
    PENCE, JC
    HUPER, G
    KINNEY, RB
    IGLEHART, JD
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (12) : 1823 - 1830